TY - JOUR
T1 - Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo
T2 - Evidence against inflammation as a driving force for amyloid deposition
AU - Chakrabarty, Paramita
AU - Jansen-West, Karen
AU - Beccard, Amanda
AU - Ceballos-Diaz, Carolina
AU - Levites, Yona
AU - Verbeeck, Christophe
AU - Zubair, Abba C.
AU - Dickson, Dennis
AU - Golde, Todd E.
AU - Das, Pritam
PY - 2010/2
Y1 - 2010/2
N2 - Proinflammatory stimuli, after amyloid β (Aβ) deposition, have been hypothesized to create a self-reinforcing positive feedback loop that increases amyloidogenic processing of the Aβ precursor protein (APP), promoting further Aβ accumulation and neuroinflammation in Alzheimer's disease (AD). Interleukin-6 (IL-6), a proinflammatory cytokine, has been shown to be increased in AD patients implying a pathological interaction. To assess the effects of IL-6 on Aβ deposition and APP processing in vivo, we overexpressed murine IL-6 (mIL-6) in the brains of APP transgenic TgCRND8 and TG2576 mice. mIL-6 expression resulted in extensive gliosis and concurrently attenuated Aβ deposition in TgCRND8 mouse brains. This was accompanied by up-regulation of glial phagocytic markers in vivo and resulted in enhanced microglia-mediated phagocytosis of Aβ aggregates in vitro. Further, mIL-6-induced neuroinflammation had no effect on APP processing in TgCRND8 and had no effect on APP processing or steady-state levels of Aβ in young Tg2576 mice. These results indicate that mIL-6-mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing Aβ plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology. This is the first study that methodically dissects the contribution of mIL-6 with regard to its potential role in modulating Aβ deposition in vivo.
AB - Proinflammatory stimuli, after amyloid β (Aβ) deposition, have been hypothesized to create a self-reinforcing positive feedback loop that increases amyloidogenic processing of the Aβ precursor protein (APP), promoting further Aβ accumulation and neuroinflammation in Alzheimer's disease (AD). Interleukin-6 (IL-6), a proinflammatory cytokine, has been shown to be increased in AD patients implying a pathological interaction. To assess the effects of IL-6 on Aβ deposition and APP processing in vivo, we overexpressed murine IL-6 (mIL-6) in the brains of APP transgenic TgCRND8 and TG2576 mice. mIL-6 expression resulted in extensive gliosis and concurrently attenuated Aβ deposition in TgCRND8 mouse brains. This was accompanied by up-regulation of glial phagocytic markers in vivo and resulted in enhanced microglia-mediated phagocytosis of Aβ aggregates in vitro. Further, mIL-6-induced neuroinflammation had no effect on APP processing in TgCRND8 and had no effect on APP processing or steady-state levels of Aβ in young Tg2576 mice. These results indicate that mIL-6-mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing Aβ plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology. This is the first study that methodically dissects the contribution of mIL-6 with regard to its potential role in modulating Aβ deposition in vivo.
KW - APP
KW - Alzheimer's disease
KW - Neuroinflammation
KW - Recombinant adeno-associated virus
UR - http://www.scopus.com/inward/record.url?scp=76149092520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=76149092520&partnerID=8YFLogxK
U2 - 10.1096/fj.09-141754
DO - 10.1096/fj.09-141754
M3 - Article
C2 - 19825975
AN - SCOPUS:76149092520
SN - 0892-6638
VL - 24
SP - 548
EP - 559
JO - FASEB Journal
JF - FASEB Journal
IS - 2
ER -